MetaCap

National Health Investors Inc. (NHI)

NYSE: NHIReal EstateREIT - Healthcare FacilitiesUSD

63.96-1.58 (-2.41%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

NHI stock chart

Technical analysis

Key statistics

All statistics
Dividend yield
5.75% ($3.68)
Ex-dividend date
Sep 30, 2026
52-week range
63.87 – 91.38
Day range
63.87 – 65.69
Volume / Avg
382.61K / 376.95K
Beta
—
Next earnings
Nov 5, 2026

52-week range

$63.87$91.38

NHI stock today

Shares of National Health Investors (NHI) finished lower on Oct 7 at $63.96, a drop of 2.41% or $1.58 per share, versus the S&P 500's 0.22% decline. Shares are 30.0% below their 52-week high of $91.38, set on Feb 17, 2026 and 0.1% above the 52-week low of $63.87, near the bottom of the past year's range. NHI is down 16.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 15.5%.

At 18.9x trailing earnings, National Health Investors trades in line with the peer-group median of 20.6x. Its forward P/E of 19.7x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. National Health Investors's next earnings report is expected on Nov 5, 2026. National Health Investors pays an annual dividend of $3.68 per share, a 5.75% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About National Health Investors

Company profile

National Health Investors, Inc. is a self-managed real estate investment trust (REIT). The Company owns, leases, operates and finances the development of high-quality real estate properties in the United States, focusing on senior housing communities and medical facilities.

Industry
REIT - Healthcare Facilities
CEO
Mr. D. Eric Mendelsohn
Headquarters
Murfreesboro, TN
Employees
32

Financial highlights

Full financials

In fiscal 2025, National Health Investors generated $375.6 million in revenue, up 12.1% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $142.2 million (+3.0% year over year), for a net margin of 37.9% versus a median of 41.2% in the prior 5 years. Diluted earnings per share came in at $3.02, down from $3.13.

National Health Investors annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$375.63M$335.18M$319.83M$278.19M$298.71M
Growth+12.07%+4.80%+14.97%-6.87%-10.24%
Net income$142.18M$137.99M$135.65M$66.40M$111.80M
EPS (diluted)$3.02$3.13$3.13$1.48$2.44

Analyst forecast

Forecast

Consensus (8 analysts)

buy

Avg. price target

$81.88+28.02%

  • Strong buy 0
  • Buy 5
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $73.00High $90.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Nov 5, 2026
EPS estimate
$1.16
Last reported (Q2 2026)
Aug 10, 2026
EPS actual vs est.
$1.15 vs —

Dividends

Dividend history
Annual dividend
$3.68
Last payment
$0.94
Ex-dividend date
Sep 30, 2026

National Health Investors peers

Real Estate sector
NHI peer companies
CompanyPrice% ChgMarket capCompare
SBRASabra Health Care REIT Inc.18.74-1.99%$4.79Bvs NHI
NHPNational Healthcare Properties Inc. Class A15.39-1.72%$1.12Bvs NHI
STRWStrawberry Fields REIT Inc.13.09-0.08%$739.84Mvs NHI
UHTUniversal Health Realty Income Trust37.29-0.35%$518.28Mvs NHI
XRNChiron Real Estate Inc.34.10-0.53%$493.77Mvs NHI
CHCTCommunity Healthcare Trust Incorporated13.58-0.37%$389.12Mvs NHI

Indexes, lists and sector

National Health Investors stock FAQ

What is National Health Investors's stock price today?

NHI last traded at $63.96 as of Oct 7, 4:00 PM EDT, down 2.41% on the day. Prices are delayed at least 15 minutes.

Does National Health Investors pay a dividend?

Yes. National Health Investors pays $3.68 per share annually, a 5.75% yield. The most recent dividend of $0.94 had an ex-dividend date of Sep 30, 2026.

When is National Health Investors's next earnings date?

National Health Investors is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $1.16.

What is NHI's P/E ratio?

NHI trades at a trailing P/E ratio of 18.92 and a forward P/E of 19.70, compared with a median of 20.6 for its closest peers.

Who is National Health Investors's CEO?

Mr. D. Eric Mendelsohn is the chief executive officer of National Health Investors Inc., which has about 32 employees.

What is the NHI 52-week high?

The 52-week high for NHI is $91.38 and the 52-week low is $63.87. The stock is currently 30.0% below its high.

Compare NHI